Angiotensin-converting enzyme gene insertion/deletion polymorphism and renal damage in childhood uropathies

Pediatrics International

Volumn 42, Issue 4, 2000, Pages 348-353

  Al Eisa, Amal ^a   Haider, Mohammad Z ^a   Srivastva, Braham S ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Angiostensin converting enzyme gene; Genotype; Polymerase chain reaction; Polymorphism; Uropathy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ALLELE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE DELETION; GENE INSERTION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; HUMAN CELL; INTRON; KIDNEY FAILURE; KIDNEY INJURY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; URINARY TRACT DISEASE;

CHILD; CHILD, PRESCHOOL; FEMALE; FRAMESHIFT MUTATION; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; KUWAIT; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM; UROGENITAL ABNORMALITIES;

EID: 0033838669     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200X.2000.01242.x     Document Type: Article

References (26)

1. Risks of angiostensin-converting enzyme inhibition during pregnancy: Experimental and clinical evidence, potential mechanisms, and recommendations for use
2. Angiostensin-converting enzyme inhibitors during pregnancy: A survey of 22 patients given captopril and nine given enalpril
3. Recognition and management of angiostensin-converting enzyme inhibitior fetopathy
4. Angiotensin-converting enzyme inhibitor fetopathy
5. ACE inhibitor fethopathy and hypocalvaria: The kidney-skull connection
6. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation
7. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology and reduced male fertility
8. Renal abnormalities in mutant mice
9. Male-female differences in fertility and blood pressure in ACE-deficient mice
10. Genetic control of blood pressure and the angiotensinogen locus
11. An insertion-deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels
12. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
13. Role of the deletion polymorphism of the angiostensin-converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy
14. Polymorphisms in angiostensin-converting enzyme gene and progression of IgA nephropathy
15. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) Study Group
16. Accelerated course of progression to chronic renal failure in NIDDM patients with the deletion polymorphism of the angiostensin-converting enzyme gene
17. Medical versus surgical treatment of primary vesicoureteral reflux
18. Renal hypoplasia and dysplasia
19. Report of the National Heart Lung and Blood Institute's Second Task Force on Blood Pressure Control in Children
20. Angiostensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis
21. Potential risk factors associated with progressive renal damage in childhood urological diseases: The role of angiotensin-converting enzyme gene polymorphism
22. ACE I/D gene polymorphism predicts renal damage in congenital uropathies
23. Role of the renin-angiotensin system in disorders of the urinary tract
24. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme
25. Converting enzyme inhibition and renal tissue angiotensin II in the rat